Drawing for UNIVERCELLS

USPTO serial 79275008

UNIVERCELLS

Reviewed by CopyMark Law Group

Reg. 6202741Status 700Renewal
Filing date
Status date
Registration date
Nov 24, 2020
Examiner
BLAZICH, JOAN MICHELE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with UNIVERCELLS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew D. Dorisio

Andrew D. Dorisio DICKINSON WRIGHT PLLC300 West Vine Street, Suite 1700Lexington, KY 40507UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Bioreactors with a controller for cell culturing and bioprocess intensification; laboratory equipment for laboratory research, clinical research and trials and for biopharmaceutical manufacturing industries, namely, cell culture isolators, cell culture vessels in the nature of bioreactors, cabinets specially adapted for cell culture, cell culture instruments in the nature of bioreactors, handling vessels in the nature of bioreactors, filtration membranes and process control equipment in the nature of controllers for monitoring and regulating cell culturing, all of the foregoing being for laboratory and scientific use; reusable and disposable bioreactors for cell culturing, for laboratory use, for research use and for biopharmaceutical and pharmaceutical manufacturing industries, all of the foregoing not for use in the treatment of wastewater and waste; bioreactors for high cell density cultivations; fixed-bed bioreactor for cell culturing, for laboratory use, for research use and for biopharmaceutical and pharmaceutical manufacturing industries, all of the foregoing not for use in the treatment of wastewater and waste; incubators for cell culture; apparatus for observing cell culture, namely, microscopes; bioreactor controllers for controlling and monitoring the biological process in the nature of cell culturing; laboratory equipment for bioprocessing, namely, self-contained bio manufacturing chambers in the nature of cell culture chambers containing environmental control and containment barriers for use in safe handling of biological materials, also for use in manufacturing of biologics, for use in laboratory; laboratory apparatus for the cultivation of microorganisms, cells, or other biological material for use in laboratory, namely, bioreactors for cell culturing; scientific instruments, apparatus and devices, including laboratory apparatus, namely, microscopes and sensors for sensing cell culture parameters; containers, namely, cell culture recipients, incorporating sensors for containing cell culture for laboratory use in the manufacturing of biologics; laboratory receptacles and laboratory equipment for cultivating, incubating, staining and analysing biological materials including microorganisms, cells and tissue, namely, bioreactors; laboratory shakers, namely, agitators for laboratory use; structural parts of the aforesaid goodsACTIVE—
042Engineering, scientific and technological consultancy on process, namely, product development relating to manufacture of biologics; engineering, scientific and technological consultancy on production units for the development and production of biologics, namely, product development; design of tools for the production of biologics; advisory services relating to industrial engineering in the field of manufacturing of biologics; biochemical engineering services; technical engineering in the field of manufacturing of biologics; rental of laboratory apparatus and instruments; product and pharmaceutical research and development for the pharmaceutical and biotechnology industries; custom design and development of chemical reagents; analytical testing services, namely, materials evaluation testing of pharmaceutical, biopharmaceutical and chemical products, featuring testing for safety, toxicity, content, identity, purity, configuration and function; providing counseling and information with regard to aforementioned servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 24, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 3, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 30, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 29, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 29, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 21, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 26, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 26, 2021FIMPFINAL DISPOSITION PROCESSED—
Feb 24, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 24, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 8, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 8, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 19, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 1, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 27, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 26, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 25, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 22, 2020RFNTREFUSAL PROCESSED BY IB—
Feb 13, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 13, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 2, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 1, 2020RFRRREFUSAL PROCESSED BY MPU—
Jan 10, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 9, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 8, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 6, 2020DOCKASSIGNED TO EXAMINER—
Jan 6, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 26, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance